EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel missense variant in TNFAIP3 associated with autoimmunity reveals the contribution of STAT1/mTOR pathways

Judith Potjewijd iD, Hans J P M Koenen, Caspar I van der Made, Esther van Rijssen, Xuehui He, Renee Ysermans, Liset Ungethum, Ruud Theunissen, Leon J Schurgers, Jan Damoiseaux iD, Pieter van Paassen, Ruben L Smeets

Clinical and Experimental Immunology · 2025

DOI: 10.1093/cei/uxaf048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2025. Verfasst von Judith Potjewijd und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Tumor Necrosis Factor alpha-Induced Protein 3, Mutation, Missense, Autoimmunity, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heterozygous loss-of-function mutations in the TNFAIP3 gene lead to A20 haploinsufficiency (HA20). A20 protein is a negative feedback regulator of NF-κB signaling. Traditionally, HA20 is associated with Behçet's disease-like symptoms, however, recent findings suggest it may also manifest with a broader array of autoimmune diseases. Here, we describe a novel TNFAIP3 variant in a Dutch family, predominantly presenting with polyautoimmunity rather than autoinflammatory manifestations. We evaluated two patients from a Dutch family with autoimmune symptoms. Whole-exome sequencing (WES) identified a heterozygous c.608T>G (p.Leu203Arg) missense variant in TNFAIP3, located within the OTU domain. Functional analyses included immunoblotting of peripheral blood mononuclear cells (PBMCs) and an overexpression model using transfected HEK293T cells. A20 protein expression was evaluated, while phosphoflow cytometry assessed phosphorylation of key signaling molecules in the NF-κB, STAT and mTOR pathways. Inflammatory cytokine production was measured in cell culture supernatants. Overexpression of this missense A20 variant in HEK293T enhanced NF-κB signaling, reflected by increased TRAF6 expression and IκBα phosphorylation. Patient-derived PBMCs demonstrated reduced A20 expression, increased phosphorylation within the NF-κB, STAT1, and mTOR pathways, and elevated production of pro-inflammatory cytokines. These molecular alterations suggest disrupted immune regulation contributing to the observed autoimmune phenotype. The identification of this novel TNFAIP3 variant contributing to HA20 expands the clinical spectrum to include predominant autoimmune manifestations. In addition to NF-κB and STAT1 activation, we discovered mTOR pathway activation, shedding new light on A20’s function and progression toward autoimmunity. Furthermore, the involvement of mTOR pathway also provides new therapeutic possibilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor alpha-Induced Protein 3Mutation, MissenseAutoimmunityTOR Serine-Threonine KinasesSTAT1 Transcription FactorAutoimmune DiseasesHumansHEK293 CellsSignal TransductionMaleFemaleNF-kappa BAdultLeukocytes, MononuclearMiddle AgedPedigree

Stichwörter der Autor:innen

A20 haploinsufficiencyNF-κBSTAT1 and mTOR pathwayTNFAIP3polyautoimmunity

Substanzen

Tumor Necrosis Factor alpha-Induced Protein 3TNFAIP3 protein, humanTOR Serine-Threonine KinasesSTAT1 Transcription FactorMTOR protein, humanSTAT1 protein, humanNF-kappa B

Autor:innen und Institutionen

  • Department of Clinical and Experimental Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Human Genetics, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
  • Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
  • Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
  • Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands.

ORCID-Profile: Judith Potjewijd, Jan Damoiseaux

Zitieren

APA

Potjewijd, J., Koenen, H. J. P. M., van der Made, C. I., van Rijssen, E., He, X., Ysermans, R., Ungethum, L., Theunissen, R., Schurgers, L. J., Damoiseaux, J., van Paassen, P., & Smeets, R. L. (2025). A novel missense variant in TNFAIP3 associated with autoimmunity reveals the contribution of STAT1/mTOR pathways. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxaf048

Vancouver

Potjewijd J, Koenen HJPM, van der Made CI, van Rijssen E, He X, Ysermans R, et al. A novel missense variant in TNFAIP3 associated with autoimmunity reveals the contribution of STAT1/mTOR pathways. Clinical and Experimental Immunology. 2025. doi:10.1093/cei/uxaf048

BibTeX
@article{Potjewijd2025,
  author = {Potjewijd, Judith and Koenen, Hans J P M and van der Made, Caspar I and van Rijssen, Esther and He, Xuehui and Ysermans, Renee and Ungethum, Liset and Theunissen, Ruud and Schurgers, Leon J and Damoiseaux, Jan and van Paassen, Pieter and Smeets, Ruben L},
  title = {A novel missense variant in TNFAIP3 associated with autoimmunity reveals the contribution of STAT1/mTOR pathways},
  journal = {Clinical and Experimental Immunology},
  year = {2025},
  doi = {10.1093/cei/uxaf048}
}
Kostenlos starten →